Regulation of mevalonate synthesis in low density lipoprotein receptor knockout mice fed n-3 or n-6 polyunsaturated fatty acids

被引:20
作者
El-Sohemy, A [1 ]
Archer, MC [1 ]
机构
[1] Univ Toronto, Fac Med, Dept Nutrit Sci, Toronto, ON M5S 3E2, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
D O I
10.1007/s11745-999-0455-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
3-Hydroxy-3-methylglutaryl (HMG)-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, catalyzes the formation of mevalonate which is also required for cell proliferation. Changes in HMG-CoA reductase may mediate the differential effects of n-3 and n-6 polyunsaturated fatty acids (PUFA) on experimental mammary tumorigenesis, but the mechanisms by which these fatty acids regulate HMG-CoA reductase are unclear. To determine whether the low density lipoprotein receptor (LDL-R) is required for this regulation, groups of female LDL-R knockout (-/-) and wild-type (+/+) mice were fed 7% fat diets rich in either n-3 (menhaden oil) or n-6 (safflower oil) PUFA for 1 wk. Dietary PUFA and deletion of the LDL-R had independent effects on HMG-CoA reductase and serum lipids, and a significant diet-gene interaction was observed. The effects of PUFA on HMG-CoA reductase in the mammary gland, but not the liver, were mediated by the LDL-R. We also observed that differences in HMG-CoA reductase and serum LDL-cholesterol, high density lipoprotein cholesterol, and triglycerides between -/- and +/+ mice were dependent on whether the mice were fed n-3 or n-6 PUFA. Differences between -/- and +/+ mice were much greater when animals were fed n-6 PUFA rather than n-3 PUFA. These results show that the LDL-R mediates the effects of PUFA on HMG-CoA reductase in the mammary gland but not the liver. Furthermore, the composition of dietary PUFA profoundly influences the effects of deleting the LDL-R on HMG-CoA reductase and serum lipids and suggests that diet may influence the phenotype of other knockout or transgenic animals.
引用
收藏
页码:1037 / 1043
页数:7
相关论文
共 30 条
[1]   Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis [J].
Alonso, DF ;
Farina, HG ;
Skilton, G ;
Gabri, MR ;
De Lorenzo, MS ;
Gomez, DE .
BREAST CANCER RESEARCH AND TREATMENT, 1998, 50 (01) :83-93
[2]  
BROWN MS, 1980, J LIPID RES, V21, P505
[3]   KOCHS POSTULATES FOR CHOLESTEROL [J].
BROWN, MS ;
GOLDSTEIN, JL .
CELL, 1992, 71 (02) :187-188
[4]   REGULATION OF HMG-COA REDUCTASE - IDENTIFICATION OF THE SITE PHOSPHORYLATED BY THE AMP-ACTIVATED PROTEIN-KINASE INVITRO AND IN INTACT RAT-LIVER [J].
CLARKE, PR ;
HARDIE, DG .
EMBO JOURNAL, 1990, 9 (08) :2439-2446
[5]  
DIETSCHY JM, 1993, J LIPID RES, V34, P1637
[6]  
DIETSCHY JM, 1983, J LIPID RES, V24, P468
[7]  
ELLSWORTH JL, 1987, J BIOL CHEM, V262, P2316
[8]  
ElSohemy A, 1997, CANCER RES, V57, P3685
[9]   REGULATION OF CHOLESTEROL-SYNTHESIS IN THE LIVER AND MAMMARY-GLAND OF THE LACTATING RAT [J].
GIBBONS, GF ;
PULLINGER, CR ;
MUNDAY, MR ;
WILLIAMSON, DH .
BIOCHEMICAL JOURNAL, 1983, 212 (03) :843-848
[10]  
GOLDSTEIN JL, 1984, J LIPID RES, V25, P1450